David Nierengarten

Stock Analyst at Wedbush

(1.12)
# 1974
Out of 5,356 analysts
300
Total ratings
36.90%
Success rate
2.46%
Average return
78 Stocks
Name Action PT Current % Upside Ratings Updated
TLX Telix Pharmaceutical...
Initiates Coverage On: Outperform
22
17.66 24.58% 1 Jun 5, 2025
BPMC Blueprint Medicines
Downgrades: Neutral
128 129
127.86 0.89% 5 Jun 2, 2025
ITOS ITeos Therapeutics
Downgrades: Neutral
10 12
10.15 18.23% 3 May 28, 2025
NTLA Intellia Therapeutic...
Reiterates: Neutral
10 10
7.58 31.93% 9 May 19, 2025
NUVB Nuvation Bio
Reiterates: Outperform
5 5
2.48 101.61% 8 May 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
29 27
16.43 64.33% 8 Apr 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
34 34
29.48 15.33% 3 Apr 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
715 715
580.35 23.2% 19 Apr 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
11 11
3.15 249.21% 3 Mar 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
33 33
9.14 261.05% 6 Mar 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
8 2
0.83 140.96% 7 Mar 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
5 5
1.35 270.37% 14 Mar 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
31 31
11.07 180.04% 2 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
77 77
46.8 64.53% 6 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
40 40
21.25 88.24% 13 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
87 90
37.66 138.98% 3 Dec 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
40 47
34.28 37.11% 7 Nov 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
6 6
n/a n/a 3 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
15 15
3.98 276.88% 6 Sep 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
99 115
78 47.44% 5 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
23 23
5.1 350.98% 3 Sep 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
20 20
9.11 119.54% 7 Sep 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
40
n/a n/a 1 Sep 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
45
16.63 170.6% 1 Sep 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
10 10
1.67 498.8% 4 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
18
1.96 818.37% 1 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
57 57
48.02 18.7% 3 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
5 5
0.37 1251.35% 8 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
5 5
n/a n/a 8 Jun 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
8 2
1.3 53.85% 4 May 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
10 10
5.99 66.94% 3 May 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
11 11
0.22 4900% 7 May 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
34 36
9.12 294.74% 6 May 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
57 57
17 235.29% 3 Apr 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
12 12
1.37 775.91% 3 Apr 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
24 24
n/a n/a 5 Mar 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
60 34
4.97 576.06% 1 Mar 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
2 7
0.36 1844.44% 2 Feb 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
5 4
n/a n/a 7 Feb 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
2 2
n/a n/a 4 Jan 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
1400 500
2.93 16964.85% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
8 5
n/a n/a 2 Oct 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
105 60
4.27 1305.15% 6 Jul 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
24 7
n/a n/a 2 Jul 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
24
n/a n/a 1 Jul 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
35 40
n/a n/a 3 May 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Jan 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Oct 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
11 19
7.87 141.42% 3 Sep 26, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Jun 27, 2022